Xtalks — The Life Science Community™, Online webinar
2026-10-20
The latest innovations in cell bank manufacturing can help accelerate biologic therapeutics program while reducing risk and simplifying overall strategy. As industry expectations continue to evolve, establishing a well-characterized cell bank requires careful consideration of manufacturing processes, contamination control, testing requirements and regulatory expectations. This webinar explores how closed processing and cell line characterization can support a regulatory-aligned pathway from GMP cell bank manufacturing through comprehensive characterization. The featured speakers will highlight key enhancements to cell bank manufacturing approaches and explore how closed processing systems support closer alignment with changing industry expectations and reduce contamination risk. The discussion will also cover comprehensive upstream capabilities across cell banking and cell line characterization, providing insight into how these activities can be considered as part of an integrated development strategy. This webinar will also examine next-generation cell line characterization for master cell banks, based on scientific rigor and appropriate risk assessments that address global regulatory guidance. It will provide pragmatic insights into evolving industry expectations and how innovative technologies, scientific expertise and integrated capabilities can establish a solid foundation for biologics programs. Register for this webinar to learn how cell bank manufacturing can reduce contamination risk, support comprehensive characterization and strengthen biologics development programs.
|